Treatment of a 4-year-old boy with mepolizumab for lymphocytic hypereosinophilic syndrome.

Ann Allergy Asthma Immunol

Division of Immunology, Department of Internal Medicine, University of Iowa Hospitals and Clinics, Iowa City, Iowa.

Published: August 2022

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.anai.2022.04.031DOI Listing

Publication Analysis

Top Keywords

treatment 4-year-old
4
4-year-old boy
4
boy mepolizumab
4
mepolizumab lymphocytic
4
lymphocytic hypereosinophilic
4
hypereosinophilic syndrome
4
treatment
1
boy
1
mepolizumab
1
lymphocytic
1

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!